The First FDA-Approved Digital Pill — What It Means For Pharma Harsha Madannavar Justin Wang Helen Chen Read more
Related Practice Life Sciences & Pharma In mid-November 2017, the U.S. FDA approved Japan-based Otsuka Pharmaceutical’s Abilify MyCite— a first for digital medicine. 07312019140709
Executive Insights Life Sciences & Pharma How the Inflation Reduction Act Will Impact the Biopharmaceutical Industry September 9, 2022
Article MedTech APAC Hospital Priorities 2022: Strategic Implications for Medtech Firms April 14, 2022
Executive Insights Life Sciences & Pharma Looking Ahead in Pharma Services: Key Trends Impacting the Industry April 14, 2022
Special Report Diagnostics, Tools and Personalized Medicine Chronic Disease Management: The Case for MedTech Health Services September 19, 2022